# Galmed Pharmaceuticals Ltd. (EOCN)

Source page: https://stoqly.net/companies/eocn

- **Ticker:** EOCN (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001595353
- **Latest annual report:** 20-F filed 2026-03-31 (https://www.sec.gov/Archives/edgar/data/1595353/000149315226014182/form20-f.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $3.10 on 2026-10-30
- **Market cap:** $3.0M
- **P/E (trailing):** 1.3x
- **EPS, trailing 12 months:** $2.39
- **Return on equity:** −64.2%
- **Change in share count:** +363.2%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/eocn/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 0 | 1 | 2 | 0 | 0 | — | — | — | — | — |
| Operating income | — | -12 | -11 | -22 | -30 | — | — | — | — | — |
| Net income | -17 | -12 | -10 | -20 | -29 | -32 | -18 | -7 | -8 | -10 |
| Diluted EPS (US$) | — | — | — | — | — | 19.80 | 127.80 | 30.00 | 8.08 | 2.39 |
| Operating cash flow | -12 | -12 | -9 | -15 | -26 | -33 | -19 | -6 | -6 | -6 |
| Free cash flow | -12 | -12 | -9 | -15 | -26 | -33 | -19 | — | — | — |
| Cash | 3 | 13 | 30 | 44 | 11 | 35 | 14 | 10 | 12 | 11 |
| Debt and leases | 1 | 0 | — | — | — | — | — | — | — | — |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.